Lungs Europe is a Brussels-based collaboration between the European Lung Foundation (ELF) and the European Respiratory Society (ERS).
Established in November 2019, Lungs Europe allows ELF and ERS to work in partnership and with other important organisations in the respiratory field to drive policy and the regulatory environment in support of lung health at the European level. Lungs Europe is well placed to play a significant role in EU funding programmes and projects related to respiratory health and disease.
ELF is a patient-led organisation that works internationally to bring patients and the public together with healthcare professionals to improve lung health and advance diagnosis, treatment and care.
ERS is the largest scientific and clinical organisation in respiratory medicine in Europe. Its members are scientists, clinicians, allied healthcare professionals and other experts from around the world.
You can find out more information about ELF and ERS activities by going directly to their individual websites:
ELF and ERS collaborate on a number of EU-funded projects that look at unmet medical and societal needs in the respiratory field. The projects address different aspects in the translational process and how observations in the clinic, laboratory or community turns into interventions that improve the health of individuals and the public.
Both ELF (headquarted in Sheffield, UK) and ERS (headquartered in Lausanne, Switzerland) can be partners in HORIZON EUROPE projects. Both organistions are also able to contribute to EU4HEALTH projects through Lungs Europe.
Current projects in which Lungs Europe is involved include:
Read more information on the projects that ELF are involved in.
Read more information on the projects that ERS are involved in.
If you are interested in involving ELF, ERS or Lungs Europe in your project, then please complete this form.
Please read our annual reports and audited accounts to see our activities across the year and found out more about our work.
View 2021 – 2022 annual report
View 2022 – 2023 annual report